AEON Biopharma, Inc. (AEON) — Shareholders' Equity
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | -$55.03M | -92.6% |
| 2024 | -$28.57M | +81.3% |
| 2023 | -$153.04M | +43.4% |
| 2022 | -$270.41M | -20.8% |
| 2021 | -$223.82M | — |
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | -$55.03M | -92.6% |
| 2024 | -$28.57M | +81.3% |
| 2023 | -$153.04M | +43.4% |
| 2022 | -$270.41M | -20.8% |
| 2021 | -$223.82M | — |